Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance

Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance

Item
http://www.wikidata.org/entity/Q33749940
Year in review 2013: Critical Care--respiratory infectionsTreatment of bloodstream infections in ICUsClinical outcomes and microbiological characteristics of severe pneumonia in cancer patients: a prospective cohort study.Assessment of Treatment of Community Acquired Severe Pneumonia by Two Different AntibioticsIs β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis.What Is New in Antibiotic Therapy in Community-Acquired Pneumonia? An Evidence-Based Approach Focusing on Combined Therapy.The Value of Macrolide-Based Regimens for Community-Acquired Pneumonia.Moxifloxacin is not anti-inflammatory in experimental pneumococcal pneumonia.Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.The dilemma of monotherapy or combination therapy in community-acquired pneumonia.Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.Appropriate antibiotic management of bacterial lower respiratory tract infections
P2860

Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance

Item
http://www.wikidata.org/entity/Q33749940
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Initial use of one or two anti ...... vival and bacterial resistance
@ast
Initial use of one or two anti ...... vival and bacterial resistance
@en
type
label
Initial use of one or two anti ...... vival and bacterial resistance
@ast
Initial use of one or two anti ...... vival and bacterial resistance
@en
prefLabel
Initial use of one or two anti ...... vival and bacterial resistance
@ast
Initial use of one or two anti ...... vival and bacterial resistance
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Initial use of one or two anti ...... vival and bacterial resistance
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P932